Brainstorm Cell Therapeutics (BCLI) EV to EBITDA (2011)
Brainstorm Cell Therapeutics' (BCLI) EV to EBITDA came in at 21.67 for Q3 2011, up 17.8% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) EV to EBITDA (2011) Analysis & Trends
For the trailing twelve months through Sep 30, 2011, EV to EBITDA at Brainstorm Cell Therapeutics was 17.86; for FY2010, it came in at 7.07.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.99 Bn | 1,139.58 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 642.25 Bn | 560.77 Bn | 17.26 Bn |
| 3 | AbbVie | 502.08 Bn | 475.19 Bn | 12.70 Bn |
| 4 | Merck | 375.61 Bn | 329.99 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.76 Bn | 266.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.66 Bn | 242.35 Bn | 12.86 Bn |
| 7 | Amgen | 241.98 Bn | 197.38 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.37 Bn | 167.57 Bn | 6.22 Bn |
| 9 | Pfizer | 172.42 Bn | 119.07 Bn | 10.94 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - |
API Access
Brainstorm Cell Therapeutics EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();